Valproate-associated coagulopathies are frequent and variable in children. - Wikidata - awgldk - TriplyDB

Valproate-associated coagulopathies are frequent and variable in children.

Valproate-associated coagulopathies are frequent and variable in children.

http://www.wikidata.org/entity/Q33372150

about

Molecular and therapeutic potential and toxicity of valproic acid Treatment of Generalized Convulsive Status Epilepticus in Pediatric Patients Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase Valproic acid-associated low fibrinogen and delayed intracranial hemorrhage: case report and mini literature review.Valproate-associated coagulopathies in children during short-term treatment.Anticonvulsant drugs and hematological disease.Safety, feasibility and complications during resective pediatric epilepsy surgery: a retrospective analysis.A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid.Antiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individuals Diffuse alveolar hemorrhage due to valproic acid: Case report and review of the literature.Technical aspects of pediatric epilepsy surgery: Report of a multicenter, multinational web-based survey by the ILAE Task Force on Pediatric Epilepsy Surgery.Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.Considerations in perioperative assessment of valproic acid coagulopathy.Seizures in low- and high-grade gliomas: current management and future outlook.The long-term safety of antiepileptic drugs.Optimizing antiepileptic drug treatment in tumoral epilepsy.Management of adverse effects of mood stabilizers.Thrombotic microangiopathy associated with Valproic acid toxicity Valproate-associated reversible encephalopathy in a 3-year-old girl with Pallister-Killian syndrome.The status of intravenous valproate for status.Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial.Simultaneous toxicities in a child on multiple anticonvulsants.Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review.Epigenetic, polymorphic and mutational (Αα167Arg→Lys) contribution to a functionally abnormal fibrinogen.Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study

P2860

Q21296867-6260B0AA-9127-4124-901F-F0A776AFE904 Q26783899-44F16AEC-A674-4CC6-9585-3332AA7DF9E9 Q27010594-775B78DF-1367-4361-8CA6-B2FC04B2DCA6 Q28543695-8206C966-451A-4347-9054-4E6C08B6B83F Q30450388-D7E24760-C558-4C4D-BD0D-F476F20C56A7 Q33384723-57588E4A-A8CD-4F7E-BA41-732555408CF3 Q33413868-05CC558F-8A38-41A5-A244-7493D379A521 Q34080105-1B496AD8-3C1F-463C-ACF9-98D21C95894C Q34806303-A0475DFF-D2FE-43FA-8C71-64039FAF0E4A Q35131181-850F570F-8BD2-4B79-BD00-7786AAC558F9 Q35215114-47DE35F6-4BD3-467B-8BF8-862C26B387D2 Q35889611-B215F1F9-665B-4216-83D2-68BF4B00322D Q36548488-BA13A4D7-ED37-4F58-BDDA-9A4451C81042 Q37589946-BA8B8E51-D6F0-4883-9363-894FFE5818BC Q37752365-48221B47-97F8-4723-87D3-EC6B80ACF41B Q38106856-2B03B3B6-0F87-45DF-92CB-34A97496767A Q38170433-85551F1F-B23C-40EF-96E3-DA70645B40EC Q38530476-9242CCD4-14CD-4E93-A74F-CE581C82186B Q41247102-4ACD2EE1-CEFA-4816-AA62-56222132D5AC Q41360043-57D5CFE3-CF51-4A58-BABD-6C6A18C35E4D Q42425055-9095EBD3-93DC-4EAA-8451-6A51ED6955FA Q42634647-424599BC-9B24-4ED0-A1E7-37902DC6B6BC Q46698735-2A465B7C-0815-4E3A-89AC-F56C414B6106 Q47566841-42F3B5E7-0CF6-4349-9E07-84DBD169CA61 Q50310711-6CFE1411-78E8-4E4C-B7B8-B68EDBDC6F9A Q57260389-3AC15765-D87F-4799-B6FD-C0C600F28592

P2860

Valproate-associated coagulopathies are frequent and variable in children.

http://www.wikidata.org/entity/Q33372150

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Valproate-associated coagulopathies are frequent and variable in children.

@ast

Valproate-associated coagulopathies are frequent and variable in children.

@en

type

label

Valproate-associated coagulopathies are frequent and variable in children.

@ast

Valproate-associated coagulopathies are frequent and variable in children.

@en

prefLabel

Valproate-associated coagulopathies are frequent and variable in children.

@ast

Valproate-associated coagulopathies are frequent and variable in children.

@en

P1433

Q33372150-A3CF5EF9-C3FB-40F6-AF97-F3BAA36B6C2C

P1476

Q33372150-09CA5F81-C5EC-47B8-827C-308027C7E70A

P2093

Q33372150-1051001F-59EE-47B0-AE9C-0F693056C133

Q33372150-24990910-F653-4FD5-96C8-47ABF1475E68

Q33372150-36BE8C6E-3DD7-4EA6-821A-A4DBFD7F4C6A

Q33372150-8ED9955B-1FFF-496C-8F50-B44EB008EF58

Q33372150-9E932313-8BB0-4352-BF3A-406A57224298

Q33372150-F6F0C3DA-34E1-4C6B-8FB7-297D63A1A3D4

P2860

Q33372150-07907F9C-7699-42F8-BDE5-FDF8C7C56536

Q33372150-0A7CB2EA-6E2B-4CD2-BE9C-D125BEBAAA1C

Q33372150-0D493DF1-D166-42A6-9C9A-0DA1AB571FB2

Q33372150-1DAE9455-3C64-421C-9567-EB62A26C94EF

Q33372150-339EF8F4-7339-420C-AFC4-E803EE7BF649

Q33372150-3A3FF1D7-BDF4-4F3E-BDCC-C684EF90B77C

Q33372150-48601A8B-0E20-4E3F-B0AD-E66C70F062EF

Q33372150-5138888A-EBF6-4153-9CEA-5F62B242E95C

Q33372150-5F4747CB-5B29-48D5-AC4A-3A77E925A99E

Q33372150-7786D196-0D5F-4FFA-9EF9-3577EDA627D6

P304

Q33372150-0114668F-CE9F-40E5-93C3-476A69596E33

P31

Q33372150-8E388D19-EBD7-4F44-9C44-FBEA6DBE6693

P356

Q33372150-5FB84414-1A9B-4A43-8404-A2AB03C9D174

P433

Q33372150-21467A63-516A-4BD9-8ADC-2D59AC31F0B1

P478

Q33372150-03A984DF-13DB-4CE1-BC4F-13B038B9E19C

P50

Q33372150-1B66A2D3-2DA6-4040-9901-8D69DCDF010B

P577

Q33372150-1622193E-0F40-401F-A103-673A50A0F597

P5875

Q33372150-782D691F-385C-41F3-95BA-77CA72B040EA

P698

Q33372150-4688F307-DF15-41E6-958A-A73973FC3D34

P356

J.1528-1167.2006.00587.X

P1433

P1476

Valproate-associated coagulopathies are frequent and variable in children.

@en

P2093

Elke Longin

http://www.w3.org/2001/XMLSchema#string

Joachim Brand

http://www.w3.org/2001/XMLSchema#string

Martin Teich

http://www.w3.org/2001/XMLSchema#string

Nellie Bell

http://www.w3.org/2001/XMLSchema#string

Stephan König

http://www.w3.org/2001/XMLSchema#string

Thorsten Gerstner

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombocytopenia associated with sodium valproate treatment.

Acute liver disease associated with sodium valproate.

Sodium valproate and bone marrow suppression.

Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.

Hematologic manifestations of long-term valproate therapy.

Preoperative valproate administration does not increase blood loss during temporal lobectomy.

The platelet aggregation in children with epilepsy receiving valproic acid.

Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid.

Adenotonsillectomy in children with von Willebrand disease.

Hematologic perturbations associated with salicylate.

P304

1136-1143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1528-1167.2006.00587.X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Carl-Erik Dempfle

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6899795

http://www.w3.org/2001/XMLSchema#string

P698

16886976

http://www.w3.org/2001/XMLSchema#string